Biomedical subjects

C Blanchat

Publications and source records attributed to C Blanchat.

6 recordsLinked to original sources

PubMed2003

A biodegradable fibrin scaffold for mesenchymal stem cell transplantation.

A potential therapy to enhance healing of bone tissue is to deliver isolated mesenchymal stem cells (MSCs) to the site of a lesion to promote bone formation. A key issue within this technology is the development of an injectable system for the delivery of MSCs. Fibrin gel exploits the final stage of the coagulation cascade in which fibrinogen molecules are cleaved by thrombin, convert into fibrin monomers and assembled into fibrils, eventually forming fibers in a three-dimensional network. This gel could have many advantages as a cell delivery vehicle in terms of biocompatibility, biodegradation and hemostasis. The objective of this study was to explore the possibility of using fibrin gel as a delivery system for human MSCs (HMSCs). To this end we have determined the optimal fibrinogen concentrations and thrombin activity for loading HMSCs in vitro into the resultant fibrin gels to obtain cell proliferation. We found that a concentration of 18 mg/ml of fibrinogen and a thrombin activity of 100 IU/ml was optimal for producing fibrin scaffolds that would allow good HMSCs spreading and proliferation. In these conditions, cells were able to proliferate and expressed alkaline phosphatase, a bone marker, in vitro. When implanted in vivo, HMSCs were able to migrate out of the fibrin gel and invade a calcium carbonate based ceramic scaffold suggesting that fibrin gel could serve as a delivery system for HMSCs.

Aged↗

PubMed2001

Long-term in vivo bioactivity and degradability of bulk sol-gel bioactive glasses.

Melt-derived bioactive glasses have been used with success in various clinical applications for over 10 years. Recently, particles of sol-gel-derived bioactive glasses with an initial high specific surface area have been shown to exhibit excellent osteoconductive properties as well as significant degradability. In this work, we explored the long-term in vivo bioactivity and degradability of bulk sol-gel-derived glasses in a rabbit model. Two sol-gel compositions (58S and 77S Bioglass) were used. Bulk 45S5 Bioglass was used as a control. Both sol-gel-derived glasses demonstrated osteoconductive properties similar to 45S5 Bioglass. In addition, absorbability was observed for both sol-gel-derived glasses starting after 12 weeks of implantation. Total absorption reached 40% after 52 weeks. No degradation could be measured in the case of bulk 45S5 melt-derived Bioglass within 1 year of implantation. The degradation process was highly time dependent, as demonstrated by regression analysis. New bone formation was found to fill in areas that had been resorbed, similar to bone remodeling. This absorbability can be assumed to be at least partially related to an osteoclastic resorption as viable osteoclasts-like cells were found to be in direct contact with the glass surfaces.

Absorbable Implants↗

PubMed2000

Experimental vertebroplasty using osteoconductive granular material.

STUDY DESIGN: Osteoporotic human cadaveric thoracic vertebral bodies and vertebral bodies from mature sheep were used as model systems to assess coral resorption and new bone formation after injection of coral granules. OBJECTIVE: To evaluate the use of natural coral exoskeleton, an osteoconductive material, for the filling of vertebral bodies. SUMMARY OF BACKGROUND DATA: Percutaneous injection of polymethylmetacrylate (PMMA) is often proposed for prophylactically stabilizing osteoporotic vertebral bodies at risk for fracture or augmentation of vertebral bodies that have already fractured. Recently, the possibility of using osteoconductive materials in granular formulation was assessed in pilot studies. METHODS: As a first step, the possibility of injecting coral granules percutaneously within osteoporotic human cadaveric thoracic vertebral bodies was assessed. As a second step, cavities were drilled into vertebral bodies of 10 mature ewes and were either left empty (control group) or filled with coral alone (CC) or coral supplemented with fibrin sealant (CC+FS). Quantitative evaluation of coral resorption and new bone formation was made 2 months and 4 months after implantation. RESULTS: The distribution of coral granules injected into human cadaveric thoracic vertebral bodies was homogenous as assayed radiographically. In the experimental animal model, osteogenesis was increased in cavities filled with coral in comparison with cavities left empty at both 2 months and 4 months (P < 0.005 and P < 0.02, respectively). Surprisingly, supplementation of coral with a fibrin sealant had no positive influence on osteogenesis (P < 0.0008 at 2 months; P < 0.002 at 4 months). In addition, it led to an increase in coral resorption by as soon as 2 months (P < 0.0008). CONCLUSION: These results demonstrate the osteoconductivity of coral in granular form for vertebral filling. Interestingly, interconnectivity between adjacent bone trabeculae and newly formed bone was restored; however, its mechanical significance remains to be determined. Further investigations are needed to evaluate the efficacy of coral in osteopenic animals and in relieving pain.

Aged↗

PubMed2000

Bioactivity of sol-gel bioactive glass coated alumina implants.

Alumina on alumina total hip arthroplasty has been in use for more than 25 years with encouraging results. However, an improvement of the alumina/bone interface still is required. The objective of this study was to investigate the in vitro and in vivo osteoconductive properties of sol-gel bioactive glass coated alumina implants. Two sol-gel glass compositions (58S Bioglass(R) and 77S Bioglass(R)) were used as coatings on alumina substrates and implanted in a rabbit model. The 58S sol-gel coating was employed in two configurations, single (A58S1) and double layer (A58S2). SEM analysis after one week in simulated body fluid revealed small crystals assumed to represent the initial phase of hydroxyapatite formation, whereas no clear conclusion could be drawn from Fourier transform infrared spectroscopy data. The percentage of bone in direct contact was greater for coated implants when compared to bulk alumina implants (p <0.001). In the case of A58S1 implants, bone percentage significantly increased from 45.1% after 3 weeks up to 87. 8% after 24 weeks of implantation (p = 0.0004). The presence of osteoid tissue, related to an aluminum release from the alumina substrates, was greatly diminished when compared to melt-derived glass-coated alumina implants.

Aluminum Oxide↗

PubMed2000

[Osteoconductive properties of bioactive glasses in a bulk form and as a coating on alumina].

INTRODUCTION: Alumina on alumina friction couple has proven its reliability in the field of total hip arthroplasty. However, loosening of the alumina socket has been responsible for most of the failures. An improvement of the bone/alumina interface could be achieved with the use of an osteconductive material as a coating on alumina. The aim of this study was to evaluate the osteconductive properties of two types of bioactive glasses as a coating on alumina substrates. MATERIALS AND METHODS: Two types of coated implants (silicate glass coated alumina - AVSi, and phosphate glass coated alumina - AVP) were evaluated in a rabbit cancellous bone model. Pure alumina implants (A) were used as negative controls and bulk glasses (silicate - VSi and original 45S5, and phosphate glasses -VP) as negative controls. Sacrifices were performed at 3, 12 and 24 weeks. The interface evaluation included histomorphometry using an image analyzer. RESULTS: Silicate glasses demonstrated high osteoconductive properties. However, non mineralized osteoid tissue was the main tissue in contact with both coated implants and bulk phosphate glasses. This tissue covered over 70 p. 100 after 24 weeks of implantation, while it was never observed around pure alumina implants after 3 weeks. DISCUSSION: Amongst the hypotheses that could explain this mineralization inhibitory process, the one involving an Al(3+) glasses contamination from Al(2) O(3) is the likeliest. The high temperature coating procedure could be responsible for alumina transformation into a more soluble phase.

Aluminum Oxide↗

PubMedDate not supplied

De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model.

Large bone defects are still a challenge to orthopedic surgeons. In this study, a massive bone defect with a clinically relevant volume was efficiently reconstructed by transplanting an engineered bone in which mesenchymal stem cells (MSCs) expanded in autologous serum (AS) were combined with a porous scaffold. In the first step, we established that the way in which the MSCs are distributed over the scaffold affects the ultimate bone-forming ability of the transplant: constructs consisting of a natural coral scaffold and a pseudo-periosteal layer of MSCs surrounding the implant (coral-MSC3D) formed significantly more bone than constructs in which the MSCs were distributed throughout the implant (p = 0.01). However, bone healing occurred in only one sheep, owing to the high resorption rate of natural coral scaffold. To overcome this problem, constructs in which MSCs were combined with a porous coralline-based hydroxyapatite (CHA) scaffold having the same architecture as natural coral but a lower resorption rate were prepared. After their implantation, these constructs were found to have the same osteogenic potential as autologous bone grafts in terms of the amount of newly formed bone present at 4 months (p = 0.89) and to have been completely replaced by newly formed, structurally competent bone within 14 months. Nevertheless, although the rate of bone healing was strikingly improved when CHA-MSC3D constructs were used (five of seven animals healed) as compared with the coral-MSC3D construct (one of seven healed), it was still less satisfactory than that obtained with autografts (five of five healed).

Animals↗